Thermodynamic aspects of latency, biochemical threshold and subclinical damage in acute intermittent porphyria

Acute Intermittent Porphyria (AHP) is a metabolic disorder characterized by the accumulation of neurotoxic and pro-oxidant precursors, particularly δ-aminolevulinic acid (ALA). Traditionally, the asymptomatic phase of these diseases has been considered a state of biological quiescence. This work proposes a paradigm shift, interpreting the pathogenesis of AHP through the lens of open-system thermodynamics and nonlinear chemical kinetics. The concept of "latency" is analyzed not as the absence of alteration, but as a steady state far from equilibrium, in which homeostatic compensation mechanisms and antioxidant reserves maintain the molecular load within subcritical limits. The "biochemical threshold" is mathematically defined as the point of enzymatic saturation and kinetic linearity breakdown, beyond which the accumulation of ALA and the generation of reactive oxygen species (ROS) trigger self-amplifying subclinical oxidative damage. By integrating normative data, the work explains the mechanism by which the transition from the latent phase to clinical manifestation occurs. This approach provides a theoretical and scientific review to support periodic multidisciplinary monitoring of latent conditions and their possible active subclinical state.